Repligen (United States)
Repligen Corporation is an American company devoted to the development and production of materials used in the manufacture of biological drugs.2014 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Repligen (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
48%
Total
Publications
203
Total Open
Publications
97
Total
Citations
7K
Open Access
Percentage
48%
Total
Publications
203
Total Open
Publications
97
Total
Citations
7K
Breakdown
Publisher Open
16%
Both
20%
Other Platform Open
12%
Closed
52%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 19%
14
Hybrid 32%
23
No Guarantees 49%
36
Other Platform Open
Domain 77%
50
Preprint 22%
14
Other Internet 15%
10
Institution 14%
9
Public 12%
8
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 50 |
Europe PMC | Domain | 28 |
DOI | Other Internet | 28 |
bioRxiv | Preprint | 8 |
University of California - eScholarship University of California | Institution | 7 |
Semantic Scholar | Public | 6 |
Figshare | Public | 6 |
University of North Texas - University of North Texas Digital Library | Other Internet | 3 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 3 |
medRxiv | Preprint | 3 |